ArticleOncoimmunology2020

Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer.

Wenlong Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.